propiomazine
Modify Date: 2024-01-08 18:50:27
propiomazine structure
|
Common Name | propiomazine | ||
|---|---|---|---|---|
| CAS Number | 362-29-8 | Molecular Weight | 340.48200 | |
| Density | 1.137g/cm3 | Boiling Point | 500.8ºC at 760mmHg | |
| Molecular Formula | C20H24N2OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 256.7ºC | |
Use of propiomazinePropiomazine is an orally active antihistamine agent with sedative effects. Propiomazine can be used in the research of insomnia[1][2]. |
| Name | propiomazine |
|---|---|
| Synonym | More Synonyms |
| Description | Propiomazine is an orally active antihistamine agent with sedative effects. Propiomazine can be used in the research of insomnia[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Propiomazine (0.2 mg/kg, nasal administration, rats) is quickly absorbed, followed by rapid reduction of the plasma concentrations[3]. Propiomazine (25 mg/kg, i.p., at 0 and 3 h after challenge) protects rats against CCl4-induced hepatic injury[4]. Propiomazine (0.31-20 mg/kg, i.v.) increases plasma prolactin concentrations in rats[5]. |
| Density | 1.137g/cm3 |
|---|---|
| Boiling Point | 500.8ºC at 760mmHg |
| Molecular Formula | C20H24N2OS |
| Molecular Weight | 340.48200 |
| Flash Point | 256.7ºC |
| Exact Mass | 340.16100 |
| PSA | 48.85000 |
| LogP | 4.89710 |
|
~%
propiomazine CAS#:362-29-8 |
| Literature: Bulletin de la Societe Chimique de France, , p. 1474,1480 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| Propiomazinum |
| 1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one |
| Propiomazinum [INN-Latin] |
| Propiomazina [INN-Spanish] |
| Wy-1359 |
| Largon |
| Dorevan |
| Phenoctyl |
| 1-[10-(2-dimethylamino-propyl)-10H-phenothiazin-2-yl]-propan-1-one |
| Propionylpromethazine |
| Propiomazina |
| 1-[10-(2-dimethylamino-propyl)-phenothiazin-2-yl]-propan-1-one |
| 10-<2-Dimethylamino-propyl>-3-propionyl-phenothiazin |
| 3-Propionyl-10-<2-dimethylamino-propyl>-phenothiazin |
| 1-[10-(2-Dimethylamino-propyl)-phenothiazin-2-yl]-propan-1-on |